Last reviewed · How we verify

NCT06885684: CoMeT

Cognitive Control and Metacognition Training

Not yet recruiting NA Last updated 20 March 2025
What this trial tests

NA trial testing Cognitive Control Training + Metacognition Coaching in Autism in 95 participants. Not yet recruiting.

Timeline
30 June 2025
Primary endpoint
28 February 2027
30 June 2027

Quick facts

Lead sponsorBoston Children's Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment95
Start date30 June 2025
Primary completion28 February 2027
Estimated completion30 June 2027

Drugs / interventions tested

Conditions studied

Sponsor

Boston Children's Hospital

Who can join

Adults 8 to 11, any sex, with Autism or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

95 autistic children (ages 8-11yrs) will be randomly assigned to a novel computer-based Cognitive Control Training combined with Metacognition Coaching or to a comparison group that receives the intervention after a delay. Before and after intervention, electroencephalography (EEG) will be used to examine engagement of the target neural responses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autism

Currently open trials in the same condition.

Other Boston Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06885684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing